Top Trending Tickers On StockTwits For February 11

By: via Benzinga
Here's a look at the top tickers trending on StockTwits.com Regeneron: Net profit lower, sees Eylea growth This morning, Regeneron Pharmaceuticals (NASDAQ: REGN ) reported its fourth quarter results. The company announced an EPS of $2.24, beating the consensus estimate of $2.08. Revenue of $610 million beat the consensus estimate of
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.